位置:首页 > 蛋白库 > GSK3B_XENLA
GSK3B_XENLA
ID   GSK3B_XENLA             Reviewed;         420 AA.
AC   Q91757; Q91627;
DT   27-JUL-2011, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   03-AUG-2022, entry version 126.
DE   RecName: Full=Glycogen synthase kinase-3 beta;
DE            Short=GSK-3 beta;
DE            EC=2.7.11.26;
DE   AltName: Full=Xgsk-3 protein;
GN   Name=gsk3b; Synonyms=Xgsk-3;
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC   Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX   NCBI_TaxID=8355;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, MUTAGENESIS OF LYS-85, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=7720580; DOI=10.1242/dev.121.3.755;
RA   Pierce S.B., Kimelman D.;
RT   "Regulation of Spemann organizer formation by the intracellular kinase
RT   Xgsk-3.";
RL   Development 121:755-765(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, MUTAGENESIS OF LYS-85, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=7667318; DOI=10.1073/pnas.92.18.8498;
RA   Dominguez I., Itoh K., Sokol S.Y.;
RT   "Role of glycogen synthase kinase 3 beta as a negative regulator of
RT   dorsoventral axis formation in Xenopus embryos.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:8498-8502(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo;
RG   NIH - Xenopus Gene Collection (XGC) project;
RL   Submitted (NOV-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=9828091; DOI=10.1006/mcne.1998.0713;
RA   Marcus E.A., Kintner C., Harris W.;
RT   "The role of GSK3beta in regulating neuronal differentiation in Xenopus
RT   laevis.";
RL   Mol. Cell. Neurosci. 12:269-280(1998).
RN   [5]
RP   FUNCTION.
RX   PubMed=11970861; DOI=10.1016/s0896-6273(02)00666-9;
RA   Moore K.B., Schneider M.L., Vetter M.L.;
RT   "Posttranslational mechanisms control the timing of bHLH function and
RT   regulate retinal cell fate.";
RL   Neuron 34:183-195(2002).
CC   -!- FUNCTION: Plays a role in the organization of the formation of the main
CC       body axis of developing embryo. Acts as an inhibitor of differentiation
CC       of primary neurons. Inhibits the ability of ectopically expressed
CC       NEUROD1 and other bHLH factors to promote early retinal cell
CC       differentiation. May participate in the Wnt signaling pathway. May
CC       regulate the circadian clock via phosphorylation of the major clock
CC       components. {ECO:0000269|PubMed:11970861, ECO:0000269|PubMed:7667318,
CC       ECO:0000269|PubMed:7720580, ECO:0000269|PubMed:9828091}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[tau protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [tau protein]; Xref=Rhea:RHEA:12801, Rhea:RHEA-COMP:13701, Rhea:RHEA-
CC         COMP:13702, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.26;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[tau protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[tau protein]; Xref=Rhea:RHEA:53904, Rhea:RHEA-COMP:13703,
CC         Rhea:RHEA-COMP:13704, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.26;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P49841}. Nucleus
CC       {ECO:0000250|UniProtKB:P49841}. Cell membrane
CC       {ECO:0000250|UniProtKB:P49841}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the unfertilized egg and throughout
CC       the early embryonic stages. Expressed in the neural plate at stage 13.
CC       Expressed throughout the eye primordia and cranial ganglia at stage 25.
CC       Highly expressed in the differentiated retinal ganglion cell layer at
CC       stage 40. {ECO:0000269|PubMed:7667318, ECO:0000269|PubMed:7720580,
CC       ECO:0000269|PubMed:9828091}.
CC   -!- PTM: Phosphorylated. Activated by phosphorylation at Tyr-216.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. GSK-3 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L38492; AAC42224.1; -; mRNA.
DR   EMBL; U31862; AAA84444.1; -; mRNA.
DR   EMBL; BC108581; AAI08582.1; -; mRNA.
DR   PIR; I51425; I51425.
DR   PIR; I51692; I51692.
DR   RefSeq; NP_001083752.1; NM_001090283.1.
DR   RefSeq; XP_018100414.1; XM_018244925.1.
DR   AlphaFoldDB; Q91757; -.
DR   SMR; Q91757; -.
DR   ELM; Q91757; -.
DR   DNASU; 399097; -.
DR   GeneID; 399097; -.
DR   KEGG; xla:399097; -.
DR   CTD; 399097; -.
DR   Xenbase; XB-GENE-865674; gsk3b.L.
DR   OrthoDB; 990896at2759; -.
DR   Proteomes; UP000186698; Chromosome 2L.
DR   Bgee; 399097; Expressed in testis and 19 other tissues.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0050321; F:tau-protein kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   CDD; cd14137; STKc_GSK3; 1.
DR   InterPro; IPR033573; GSK3B.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR039192; STKc_GSK3.
DR   PANTHER; PTHR24057:SF8; PTHR24057:SF8; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Biological rhythms; Cell membrane; Cytoplasm;
KW   Developmental protein; Differentiation; Kinase; Membrane; Neurogenesis;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Wnt signaling pathway.
FT   CHAIN           1..420
FT                   /note="Glycogen synthase kinase-3 beta"
FT                   /id="PRO_0000412070"
FT   DOMAIN          56..340
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..50
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          384..420
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..28
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        181
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         62..70
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         85
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MUTAGEN         85
FT                   /note="K->R: Inhibits enzymatic activity. Induces
FT                   duplication of the anterior dorsal axis."
FT                   /evidence="ECO:0000269|PubMed:7667318,
FT                   ECO:0000269|PubMed:7720580"
FT   CONFLICT        55
FT                   /note="T -> S (in Ref. 2; AAA84444)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        88
FT                   /note="L -> P (in Ref. 2; AAA84444)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        336
FT                   /note="A -> V (in Ref. 2; AAA84444)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        399
FT                   /note="D -> N (in Ref. 2; AAA84444)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   420 AA;  46903 MW;  C02280BB8A35785D CRC64;
     MSGRPRTTSF AESCKPVQQP SSFGSMKVSR DKDGSKVTTV VATPGQGPDR QQEVTYTDTK
     VIGNGSFGVV YQAKLCDTGE LVAIKKVLQD KRFKNRELQI MRKLDHCNIV RLRYFFYSSG
     EKKDEVYLNL VLDYVPETVY RVARHYSRAK QALPIIYVKL YMYQLFRSLA YIHSFGICHR
     DIKPQNLLLD PETAVLKLCD FGSAKQLVRG EPNVSYICSR YYRAPELIFG ATDYTSSIDV
     WSAGCVLAEL LLGQPIFPGD SGVDQLVEII KVLGTPTREQ IREMNPNYTE FKFPQIKAHP
     WTKVFRARTP PEAIALCSRL LEYTPTSRLT PLDACAHSFF DELRDPNLKL PNGREFPALF
     NFTTQELSSN PSLSSILIPA HARNQAAVST TSNTTSTSDS NTGERGSTNN AASASASNSS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024